Adaptive Biotechnologies Corp — Form D
Adaptive Biotechnologies Corp of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2012-06-21. The offering totals $5.0M, of which $2.6M was reported sold. Industry: Other.
Offering
- Filed: 2012-06-21
- Form: D
- Accession: 0001478320-12-000002
- Industry: Other
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $2.6M
- Remaining: $2.4M
- Investors: 37
- Date of first sale: 2012-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-180128
Issuer
- Name: Adaptive Biotechnologies Corp
- CIK: 0001478320
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2009
- Address: 1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, 98102
- Phone: 206-659-0067
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Craig Weissman | Director | SAN FRANCISCO, CA |
| Andy Zoltners | Director | Seattle, WA |
| Harlan Robins | Director | Seattle, WA |
| Harlan Robins | Executive Officer | Seattle, WA |
| Chad Robins | Director | Seattle, WA |
| Chad Robins | Executive Officer | Seattle, WA |
| ARNOLD LEVINE | Director | Durham, NC |
| Rob Rosen | Director | Washington, DC |
| Peter Neupert | Director | RALEIGH, NC |
| Tom Willis | Director | South San Francisco, CA |
| Chris Carlson | Executive Officer | Sioux Falls, SD |
| Lee Huntsman | Director | Seattle, WA |
| Andris Zoltners | Director | SEATTLE, WA |
| Kathleen Determann | Executive Officer | SEATTLE, WA |
| Rob Hershberg | Director | SEATTLE, WA |
| Dean Schorno | Executive Officer | SEATTLE, WA |
| John Stuelpnagel | Director | SEATTLE, WA |
| Chad Cohen | Director | SEATTLE, WA |
Other filings by this issuer (8)
More